Canada markets closed

Constellation Pharmaceuticals, Inc. (CNST)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
26.80+1.60 (+6.35%)
At close: 4:00PM EST

27.50 +0.70 (2.61%)
After hours: 6:46PM EST

Currency in USD

Valuation Measures

Market Cap (intraday) 51.28B
Enterprise Value 3788.76M
Trailing P/E N/A
Forward P/E 1-7.20
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.12
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-6.35

Trading Information

Stock Price History

Beta (5Y Monthly) 2.77
52-Week Change 3-31.32%
S&P500 52-Week Change 326.90%
52 Week High 350.90
52 Week Low 317.00
50-Day Moving Average 333.21
200-Day Moving Average 326.35

Share Statistics

Avg Vol (3 month) 3633.35k
Avg Vol (10 day) 3823.94k
Shares Outstanding 547.86M
Float 32.48M
% Held by Insiders 10.75%
% Held by Institutions 1104.22%
Shares Short (Feb. 11, 2021) 45.79M
Short Ratio (Feb. 11, 2021) 412.45
Short % of Float (Feb. 11, 2021) 417.69%
Short % of Shares Outstanding (Feb. 11, 2021) 412.12%
Shares Short (prior month Jan. 14, 2021) 45.68M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Dec. 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-18.56%
Return on Equity (ttm)-33.77%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -124.2M
Net Income Avi to Common (ttm)-126.35M
Diluted EPS (ttm)-2.82
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)421.45M
Total Cash Per Share (mrq)8.81
Total Debt (mrq)4.23M
Total Debt/Equity (mrq)1.03
Current Ratio (mrq)14.03
Book Value Per Share (mrq)8.60

Cash Flow Statement

Operating Cash Flow (ttm)-111.42M
Levered Free Cash Flow (ttm)-62.73M